Paul D. Rubin, Chief Medical Officer of BioAge Labs ($BIOA), made five open market sales of company shares over the past year, totaling about $1.3 million. His most recent sale occurred on March 2, 2026. These transactions rank him 4,329th among 11,678 insiders by sale value, well below the average of $8.6 million across roughly 6.4 sales per insider. Rubin recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Common Stock | 5437 | $4.11 | 5,437.0000 | 35,855,037 | 9999.99% | 0.02% |
| April 1, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Stock Option (Right to Buy) | 3383 | $0.00 | 0.0000 | 35,855,037 | 100.00% | 0.01% |
| April 1, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Stock Option (Right to Buy) | 5437 | $0.00 | 0.0000 | 35,855,037 | 100.00% | 0.02% |
| April 1, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | S | Common Stock | 8820 | $17.81 | 0.0000 | 35,855,037 | 100.00% | 0.02% |
| April 1, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Common Stock | 3383 | $6.57 | 8,820.0000 | 35,855,037 | 62.22% | 0.01% |
| March 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Common Stock | 5433 | $4.11 | 5,433.0000 | 35,855,037 | 9999.99% | 0.02% |
| March 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Stock Option (Right to Buy) | 2000 | $0.00 | 3,383.0000 | 35,855,037 | 37.15% | 0.01% |
| March 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Stock Option (Right to Buy) | 5433 | $0.00 | 5,437.0000 | 35,855,037 | 49.98% | 0.02% |
| March 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | S | Common Stock | 7433 | $20.30 | 0.0000 | 35,855,037 | 100.00% | 0.02% |
| March 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Common Stock | 2000 | $6.57 | 7,433.0000 | 35,855,037 | 36.81% | 0.01% |
| Feb. 17, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | A | Stock Option (Right to Buy) | 110000 | $0.00 | 110,000.0000 | 35,855,037 | 9999.99% | 0.31% |
| Feb. 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | S | Common Stock | 7433 | $18.75 | 0.0000 | 35,855,037 | 100.00% | 0.02% |
| Feb. 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Common Stock | 5433 | $4.11 | 5,433.0000 | 35,855,037 | 9999.99% | 0.02% |
| Feb. 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Common Stock | 2000 | $6.57 | 7,433.0000 | 35,855,037 | 36.81% | 0.01% |
| Feb. 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Stock Option (Right to Buy) | 5433 | $0.00 | 10,870.0000 | 35,855,037 | 33.33% | 0.02% |
| Feb. 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Stock Option (Right to Buy) | 2000 | $0.00 | 5,383.0000 | 35,855,037 | 27.09% | 0.01% |
| Jan. 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Common Stock | 5433 | $4.11 | 5,433.0000 | 35,855,037 | 9999.99% | 0.02% |
| Jan. 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Stock Option (Right to Buy) | 2000 | $0.00 | 7,383.0000 | 35,855,037 | 21.32% | 0.01% |
| Jan. 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Stock Option (Right to Buy) | 5433 | $0.00 | 16,303.0000 | 35,855,037 | 25.00% | 0.02% |
| Jan. 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | S | Common Stock | 7433 | $12.85 | 0.0000 | 35,855,037 | 100.00% | 0.02% |
| Jan. 2, 2026 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Common Stock | 2000 | $6.57 | 7,433.0000 | 35,855,037 | 36.81% | 0.01% |
| Dec. 9, 2025 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | S | Common Stock | 18000 | $12.00 | 0.0000 | 35,855,037 | 100.00% | 0.05% |
| Dec. 9, 2025 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Stock Option (Right to Buy) | 18000 | $0.00 | 9,383.0000 | 35,855,037 | 65.73% | 0.05% |
| Dec. 9, 2025 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Common Stock | 18000 | $6.57 | 18,000.0000 | 35,855,037 | 9999.99% | 0.05% |
| Dec. 4, 2025 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | S | Common Stock | 68897 | $10.19 | 0.0000 | 35,855,037 | 100.00% | 0.19% |
| Dec. 4, 2025 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Stock Option (Right to Buy) | 68897 | $0.00 | 21,736.0000 | 35,855,037 | 76.02% | 0.19% |
| Dec. 4, 2025 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | M | Common Stock | 68897 | $4.11 | 68,897.0000 | 35,855,037 | 9999.99% | 0.19% |
| Feb. 18, 2025 | BioAge Labs, Inc. | $BIOA | RUBIN PAUL D | Chief Medical Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |